申请人:GLAXO GROUP LIMITED
公开号:EP1586567A1
公开(公告)日:2005-10-19
There are provided according to the invention, novel compounds of formula (I)
wherein R1, R2, R3, R4, R5, R6, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
根据本发明提供了式 (I) 的新型化合物
其中 R1、R2、R3、R4、R5、R6、X、a、b 和 Z 如说明书中所定义,还提供了制备它们的工艺、含有它们的制剂以及它们在治疗炎症性疾病中的用途。